FilingReader Intelligence
WuXi Biologics repurchases additional shares for cancellation
July 9, 2025 at 12:30 PM UTC•By FilingReader AI
WuXi Biologics (Cayman) Inc. announced today it repurchased an additional 11,500,000 ordinary shares on the Hong Kong Exchange for cancellation. The shares were bought back at prices ranging from HKD 25.65 to HKD 26.15, with the total consideration paid amounting to HKD 297,954,625. This repurchase follows a previous buyback of 11,680,000 shares on July 8, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when WuXi Biologics (Cayman) Inc publishes news
Free account required • Unsubscribe anytime